CD5 and leukemia: These researchers concluded that 4-1BB-based CD5-redirected CAR-Ts equipped with the Tet-Off system demonstrated superior and more prolonged leukemia repression in comparison with CD28-based CD5-redirected CAR-Ts in preclinical xenograft models [54].